+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Drug Delivery Systems Market - Global Forecast to 2030- Product Image
Drug Delivery Systems Market - Global Forecast to 2030- Product Image
Sale

Drug Delivery Systems Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 199 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6013573
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Drug Delivery Systems Market grew from USD 39.02 billion in 2024 to USD 41.29 billion in 2025. It is expected to continue growing at a CAGR of 5.76%, reaching USD 54.64 billion by 2030.

The field of drug delivery systems has undergone a remarkable evolution, driven by advances in materials science, biotechnology, and patient-centric design. From simple oral formulations to sophisticated nanoparticle carriers, the quest to optimize therapeutic efficacy and safety has intensified. This executive summary frames the critical forces reshaping the landscape: technological breakthroughs, regulatory dynamics, and global trade developments. Against the backdrop of escalating chronic disease burdens and rising healthcare costs, innovators are exploring controlled release platforms, minimally invasive administration, and digital integration to enhance compliance and outcomes. As stakeholders grapple with shifting reimbursement models and geopolitical uncertainties, understanding the interplay between emerging modalities and market drivers becomes essential. This analysis synthesizes key trends, tariff impacts, segmentation patterns, regional nuances, and competitive strategies to equip decision-makers with actionable insights. By translating complex data into a clear narrative, this summary illuminates the transformative journey from concept to clinic, laying the groundwork for strategic investment and collaboration in next-generation drug delivery.

Transformative Shifts Accelerating Next-Generation Drug Delivery

Over the past decade, three pivotal shifts have redefined drug delivery. First, the rise of nanotechnology has enabled precision targeting and controlled release, reducing off-target effects and unlocking new therapeutic windows. Lipid-based nanocarriers, polymeric constructs, and inorganic nanoparticles now form the backbone of tailored dosing strategies. Second, patient empowerment has driven self-administration platforms-ranging from auto-injectors to microneedle patches-that improve adherence and expand care beyond traditional settings. Digital sensors and closed-loop infusion pumps further blur the line between therapy and real-time monitoring. Third, sustainability and regulatory alignment are gaining prominence. Companies are adopting greener manufacturing practices while navigating harmonized guidelines across major markets. This confluence of innovation, patient focus, and compliance has accelerated collaboration between pharma, medtech, and contract development organizations. As a result, the industry is poised for a new era of integrated solutions that marry biological insight with engineering precision.

Assessing the 2025 Tariff Impact on Supply Chain Resilience

In 2025, new United States tariffs on active pharmaceutical ingredients and device components have introduced fresh complexity to global supply chains. Manufacturers are experiencing upward pressure on raw material costs, particularly for specialty polymers and lipid excipients sourced from Asia and Europe. Device producers reliant on precision injection molding and microfabrication are also recalibrating procurement strategies to mitigate tariff burdens. Rather than absorbing cost increases, many players are exploring near-shoring options and dual-sourcing agreements. This strategic realignment extends to toll manufacturing partnerships and vertical integration, reducing exposure to tariff volatility. Meanwhile, regulatory agencies have signaled a willingness to expedite approvals for domestically produced formulations, incentivizing onshore capacity expansion. Although these measures may initially slow new product launches due to retooling and qualification processes, they promise long-term resilience. By proactively reassessing supplier networks and investing in localized infrastructure, companies can transform tariff-induced challenges into opportunities for efficiency and supply continuity.

Dissecting Core Segmentation to Identify Growth and Innovation Hotspots

A nuanced understanding of market segmentation reveals where investment and innovation are converging. Technology-led platforms such as nanoparticle drug delivery, encompassing inorganic, lipid-based carriers (including nanostructured lipid carriers and solid lipid nanoparticles) and polymeric systems (nanocapsules and nanospheres), are unlocking targeted oncology and neurology therapies. Transdermal formats, which integrate iontophoresis, microneedles-both hollow and solid-and sonophoresis, are gaining traction for chronic pain and hormone replacement. Concurrently, conventional and controlled release modalities complement these advanced systems where cost constraints prevail. Route of administration insights highlight inhalation devices, ocular gel formulations and liquid drops, oral solid forms, and parenteral solutions via intravenous and subcutaneous pathways, with the latter supported by auto-injectors and pre-filled syringes. Device innovations span infusion pumps-now featuring closed-loop control-metered dose inhalers, nebulizers, and sophisticated transdermal patches differentiated by matrix and reservoir designs. Patient demographics underscore the growing importance of geriatric care in home and long-term facilities alongside adult and pediatric segments. End-user dynamics range from ambulatory care centers and clinics to home care and hospital settings. Finally, therapeutic applications emphasize cardiovascular disease targets such as arrhythmia and heart failure, as well as unmet needs in neurology and oncology.

Unpacking Regional Variations in Adoption and Innovation

Regional dynamics are shaping strategic priorities. In the Americas, robust reimbursement frameworks and advanced manufacturing ecosystems support rapid adoption of cutting-edge delivery platforms. Public-private collaborations are driving pilot programs for home infusion and connected devices, while regulatory authorities emphasize biocompatibility and cybersecurity standards. Across Europe, the Middle East & Africa, harmonization under the European Medicines Agency and Gulf Cooperation Council initiatives is streamlining cross-border approvals, though cost containment pressures persist in many markets. Localized production and public health partnerships are emerging as tools to balance affordability with technological progress. Meanwhile, Asia-Pacific markets are experiencing explosive growth due to expanding middle-class populations, digital health integration, and government incentives for biotech clusters. Nations such as China, India, and South Korea are investing heavily in research infrastructure and contract development, positioning the region as both a manufacturing powerhouse and a hub for first-in-class delivery systems.

Profiling Key Industry Players and Their Strategic Initiatives

Leading companies are shaping the competitive landscape through diverse strategies. Abbott Laboratories continues to expand its self-administration device portfolio, integrating smart sensors with insulin pumps. AptarGroup, Inc. is optimizing its aerosol and nasal spray technologies to support vaccine and respiratory therapeutics. AstraZeneca Plc is collaborating with contract manufacturers to accelerate nanoparticle oncology agents through phase-II trials. Boston Scientific Corporation leverages its implantable pump expertise for targeted neurostimulation therapies. Cospheric LLC and Polysciences Inc. are driving material innovations in polymeric nanoparticle cores, while DelSiTech Ltd. is pioneering pH-responsive injectable depots. Enable Injections, Inc. focuses on large-volume wearable injectors, and F. Hoffmann-La Roche Ltd. is co-developing antibody conjugates with advanced release platforms. Insulet Corporation’s tubeless patch pump is gaining scale, complemented by Johnson & Johnson Services, Inc.’s combination device offerings. Lonza Group Ltd. and Thermo Fisher Scientific Inc. are enhancing end-to-end CDMO solutions, and Merck KGaA is integrating lipid-based carriers into mRNA delivery. Merit Medical Systems, Inc. and Terumo Corporation are optimizing catheter-based drug infusion, while Novartis AG advances its ocular gene therapy pipeline. Pacira BioSciences, Inc. leverages sustained-release local analgesic formulations, and Pfizer Inc. is advancing transdermal vaccine patches. Sanofi S.A. is aligning its biologics division with microneedle technologies developed by SHL Medical. Societal CDMO by CoreRx, Inc. is capitalizing on bespoke small-batch production, and West Pharmaceutical Services, Inc. continues to innovate container-closure platforms for high-viscosity biologics.

Actionable Strategies to Sustain Competitive Advantage

To thrive in this dynamic environment, industry leaders should prioritize several strategic actions. First, accelerating investment in nanoparticle and transdermal platforms will capture demand for precision therapies and at-home administration. Second, diversifying supply chains through near-shoring and multi-tier sourcing will hedge against tariff fluctuations and geopolitical risk. Third, forging partnerships between device engineers, polymer scientists, and digital health specialists can create integrated delivery ecosystems that improve patient engagement and data analytics. Fourth, engaging proactively with regulators to shape emerging guidelines on cybersecurity, sustainability, and biocompatibility will streamline product approvals. Fifth, adopting modular manufacturing frameworks and continuous processing technologies will enhance flexibility and reduce time to market. Sixth, cultivating talent in interdisciplinary fields-such as pharma-engineering and bioinformatics-will ensure the workforce can support complex combination products. By executing these recommendations in tandem, organizations can build resilience while capitalizing on the most promising segments in drug delivery.

Conclusion on Navigating the Future of Drug Delivery

The drug delivery landscape stands at a pivotal juncture. Technological innovations, tariff-driven supply chain realignments, nuanced segmentation, and regional differentiation are collectively driving a wave of transformation. Industry leaders who embrace an integrated approach-blending advanced carriers, patient-centric devices, and digital connectivity-will set new standards for therapeutic efficacy and convenience. At the same time, strategic agility in procurement and regulatory engagement will underpin operational resilience. By leveraging insights from segmentation and competitive benchmarking, organizations can allocate resources toward high-impact platforms and markets. Ultimately, the convergence of science, engineering, and data analytics offers an unprecedented opportunity to redefine how therapies are delivered and experienced.

Market Segmentation & Coverage

This research report categorizes the Drug Delivery Systems Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Controlled Drug Delivery
  • Conventional Drug Delivery
  • Nanoparticle Drug Delivery
    • Inorganic Nanoparticles
    • Lipid-Based Nanoparticles
      • Nanostructured Lipid Carriers
      • Solid Lipid Nanoparticles
    • Polymeric Nanoparticles
      • Nanocapsules
      • Nanospheres
  • Self-Administration
  • Self-Emulsifying Drug Delivery
  • Transdermal Drug Delivery
    • Iontophoresis
    • Microneedles
      • Hollow Microneedles
      • Solid Microneedles
    • Sonophoresis
  • Inhalation
  • Ocular
    • Gel Formulations
    • Liquid Drops
  • Oral
  • Parenteral
    • Intravenous
    • Subcutaneous
      • Auto-Injectors
      • Pre-Filled Syringes
  • Topical
  • Infusion Pumps
    • Closed-Loop Infusion Pumps
  • Metered Dose Inhalers
  • Nebulizers
  • Transdermal Patches
    • Matrix Patches
    • Reservoir Patches
  • Adults
  • Geriatric
    • Home Care Settings
    • Long-Term Care Facilities
  • Pediatric
  • Ambulatory Care Centers
  • Clinics
  • Home Care
  • Hospitals
  • Cardiovascular Diseases
    • Arrhythmia
    • Heart Failure
  • Neurology
  • Oncology

This research report categorizes the Drug Delivery Systems Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Drug Delivery Systems Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Abbott Laboratories
  • AptarGroup, Inc.
  • AstraZeneca Plc
  • Boston Scientific Corporation
  • Cospheric LLC
  • DelSiTech Ltd.
  • Enable Injections, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Insulet Corporation
  • Johnson & Johnson Services, Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • Merit Medical Systems, Inc.
  • Novartis AG
  • Pacira BioSciences, Inc.
  • Pfizer Inc.
  • Polysciences Inc.
  • Sanofi S.A.
  • SHL Medical
  • Societal CDMO by CoreRx, Inc.
  • Terumo Corporation
  • Thermo Fisher Scientific Inc.
  • West Pharmaceutical Services, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Drug Delivery Systems Market, by Technology
8.1. Introduction
8.2. Controlled Drug Delivery
8.3. Conventional Drug Delivery
8.4. Nanoparticle Drug Delivery
8.4.1. Inorganic Nanoparticles
8.4.2. Lipid-Based Nanoparticles
8.4.2.1. Nanostructured Lipid Carriers
8.4.2.2. Solid Lipid Nanoparticles
8.4.3. Polymeric Nanoparticles
8.4.3.1. Nanocapsules
8.4.3.2. Nanospheres
8.5. Self-Administration
8.6. Self-Emulsifying Drug Delivery
8.7. Transdermal Drug Delivery
8.7.1. Iontophoresis
8.7.2. Microneedles
8.7.2.1. Hollow Microneedles
8.7.2.2. Solid Microneedles
8.7.3. Sonophoresis
9. Drug Delivery Systems Market, by Route of Administration
9.1. Introduction
9.2. Inhalation
9.3. Ocular
9.3.1. Gel Formulations
9.3.2. Liquid Drops
9.4. Oral
9.5. Parenteral
9.5.1. Intravenous
9.5.2. Subcutaneous
9.5.2.1. Auto-Injectors
9.5.2.2. Pre-Filled Syringes
9.6. Topical
10. Drug Delivery Systems Market, by Device Type
10.1. Introduction
10.2. Infusion Pumps
10.2.1. Closed-Loop Infusion Pumps
10.3. Metered Dose Inhalers
10.4. Nebulizers
10.5. Transdermal Patches
10.5.1. Matrix Patches
10.5.2. Reservoir Patches
11. Drug Delivery Systems Market, by Patient Type
11.1. Introduction
11.2. Adults
11.3. Geriatric
11.3.1. Home Care Settings
11.3.2. Long-Term Care Facilities
11.4. Pediatric
12. Drug Delivery Systems Market, by End-User
12.1. Introduction
12.2. Ambulatory Care Centers
12.3. Clinics
12.4. Home Care
12.5. Hospitals
13. Drug Delivery Systems Market, by Therapeutic Application
13.1. Introduction
13.2. Cardiovascular Diseases
13.2.1. Arrhythmia
13.2.2. Heart Failure
13.3. Neurology
13.4. Oncology
14. Americas Drug Delivery Systems Market
14.1. Introduction
14.2. Argentina
14.3. Brazil
14.4. Canada
14.5. Mexico
14.6. United States
15. Asia-Pacific Drug Delivery Systems Market
15.1. Introduction
15.2. Australia
15.3. China
15.4. India
15.5. Indonesia
15.6. Japan
15.7. Malaysia
15.8. Philippines
15.9. Singapore
15.10. South Korea
15.11. Taiwan
15.12. Thailand
15.13. Vietnam
16. Europe, Middle East & Africa Drug Delivery Systems Market
16.1. Introduction
16.2. Denmark
16.3. Egypt
16.4. Finland
16.5. France
16.6. Germany
16.7. Israel
16.8. Italy
16.9. Netherlands
16.10. Nigeria
16.11. Norway
16.12. Poland
16.13. Qatar
16.14. Russia
16.15. Saudi Arabia
16.16. South Africa
16.17. Spain
16.18. Sweden
16.19. Switzerland
16.20. Turkey
16.21. United Arab Emirates
16.22. United Kingdom
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Abbott Laboratories
17.3.2. AptarGroup, Inc.
17.3.3. AstraZeneca Plc
17.3.4. Boston Scientific Corporation
17.3.5. Cospheric LLC
17.3.6. DelSiTech Ltd.
17.3.7. Enable Injections, Inc.
17.3.8. F. Hoffmann-La Roche Ltd.
17.3.9. Insulet Corporation
17.3.10. Johnson & Johnson Services, Inc.
17.3.11. Lonza Group Ltd.
17.3.12. Merck KGaA
17.3.13. Merit Medical Systems, Inc.
17.3.14. Novartis AG
17.3.15. Pacira BioSciences, Inc.
17.3.16. Pfizer Inc.
17.3.17. Polysciences Inc.
17.3.18. Sanofi S.A.
17.3.19. SHL Medical
17.3.20. Societal CDMO by CoreRx, Inc.
17.3.21. Terumo Corporation
17.3.22. Thermo Fisher Scientific Inc.
17.3.23. West Pharmaceutical Services, Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. DRUG DELIVERY SYSTEMS MARKET MULTI-CURRENCY
FIGURE 2. DRUG DELIVERY SYSTEMS MARKET MULTI-LANGUAGE
FIGURE 3. DRUG DELIVERY SYSTEMS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2030 (%)
FIGURE 18. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. DRUG DELIVERY SYSTEMS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. DRUG DELIVERY SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. DRUG DELIVERY SYSTEMS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CONTROLLED DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CONVENTIONAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY NANOPARTICLE DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY INORGANIC NANOPARTICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIPID-BASED NANOPARTICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY NANOSTRUCTURED LIPID CARRIERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SOLID LIPID NANOPARTICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIPID-BASED NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMERIC NANOPARTICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY NANOCAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY NANOSPHERES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMERIC NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY NANOPARTICLE DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SELF-ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SELF-EMULSIFYING DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY IONTOPHORESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MICRONEEDLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HOLLOW MICRONEEDLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SOLID MICRONEEDLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SONOPHORESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY INHALATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY OCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GEL FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIQUID DROPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY OCULAR, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY AUTO-INJECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRE-FILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SUBCUTANEOUS, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CLOSED-LOOP INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY METERED DOSE INHALERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATRIX PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY RESERVOIR PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY LONG-TERM CARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ARRHYTHMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY NANOPARTICLE DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIPID-BASED NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMERIC NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY OCULAR, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY SUBCUTANEOUS, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY NANOPARTICLE DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIPID-BASED NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMERIC NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY OCULAR, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY SUBCUTANEOUS, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY NANOPARTICLE DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIPID-BASED NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMERIC NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY OCULAR, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SUBCUTANEOUS, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 129. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 130. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY NANOPARTICLE DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 131. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIPID-BASED NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 132. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMERIC NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 133. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 134. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 135. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 136. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY OCULAR, 2018-2030 (USD MILLION)
TABLE 137. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 138. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY SUBCUTANEOUS, 2018-2030 (USD MILLION)
TABLE 139. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 140. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 141. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 142. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 143. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 144. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 145. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 147. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 148. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY NANOPARTICLE DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 149. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIPID-BASED NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 150. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMERIC NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 151. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 152. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 153. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 154. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY OCULAR, 2018-2030 (USD MILLION)
TABLE 155. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 156. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY SUBCUTANEOUS, 2018-2030 (USD MILLION)
TABLE 157. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 158. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 159. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 160. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 161. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 162. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 163. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 165. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 166. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY NANOPARTICLE DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 167. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIPID-BASED NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 168. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMERIC NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 169. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 170. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 171. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 172. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY OCULAR, 2018-2030 (USD MILLION)
TABLE 173. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 174. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY SUBCUTANEOUS, 2018-2030 (USD MILLION)
TABLE 175. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 176. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 177. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 178. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 179. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 180. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 181. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 183. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 184. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 185. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY NANOPARTICLE DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 186. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIPID-BASED NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 187. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMERIC NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 188. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 189. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 190. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 191. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY OCULAR, 2018-2030 (USD MILLION)
TABLE 192. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 193. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY SUBCUTANEOUS, 2018-2030 (USD MILLION)
TABLE 194. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 195. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 196. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 197. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 198. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 199. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 200. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 202. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 203. AUSTRALIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 204. AUSTRALIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY NANOPARTICLE DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 205. AUSTRALIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIPID-BASED NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 206. AUSTRALIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMERIC NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 207. AUSTRALIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 208. AUSTRALIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 209. AUSTRALIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 210. AUSTRALIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY OCULAR, 2018-2030 (USD MILLION)
TABLE 211. AUSTRALIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 212. AUSTRALIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY SUBCUTANEOUS, 2018-2030 (USD MILLION)
TABLE 213. AUSTRALIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 214. AUSTRALIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 215. AUSTRALIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 216. AUSTRALIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 217. AUSTRALIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 218. AUSTRALIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 219. AUSTRALIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. AUSTRALIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 221. CHINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 222. CHINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY NANOPARTICLE DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 223. CHINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIPID-BASED NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 224. CHINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMERIC NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 225. CHINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 226. CHINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 227. CHINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 228. CHINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY OCULAR, 2018-2030 (USD MILLION)
TABLE 229. CHINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 230. CHINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY SUBCUTANEOUS, 2018-2030 (USD MILLION)
TABLE 231. CHINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 232. CHINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 233. CHINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 234. CHINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 235. CHINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 236. CHINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 237. CHINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. CHINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 239. INDIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 240. INDIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY NANOPARTICLE DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 241. INDIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIPID-BASED NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 242. INDIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMERIC NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 243. INDIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 244. INDIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 245. INDIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 246. INDIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY OCULAR, 2018-2030 (USD MILLION)
TABLE 247. INDIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 248. INDIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY SUBCUTANEOUS, 2018-2030 (USD MILLION)
TABLE 249. INDIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 250. INDIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 251. INDIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 252. INDIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 253. INDIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 254. INDIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 255. INDIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. INDIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 257. INDONESIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 258. INDONESIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY NANOPARTICLE DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 259. INDONESIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIPID-BASED NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 260. INDONESIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMERIC NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 261. INDONESIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 262. INDONESIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 263. INDONESIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 264. INDONESIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY OCULAR, 2018-2030 (USD MILLION)
TABLE 265. INDONESIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 266. INDONESIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY SUBCUTANEOUS, 2018-2030 (USD MILLION)
TABLE 267. INDONESIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 268. INDONESIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 269. INDONESIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 270. INDONESIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 271. INDONESIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 272. INDONESIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 273. INDONESIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. INDONESIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 275. JAPAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 276. JAPAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY NANOPARTICLE DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 277. JAPAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIPID-BASED NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 278. JAPAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMERIC NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 279. JAPAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 280. JAPAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 281. JAPAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 282. JAPAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY OCULAR, 2018-2030 (USD MILLION)
TABLE 283. JAPAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 284. JAPAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY SUBCUTANEOUS, 2018-2030 (USD MILLION)
TABLE 285. JAPAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 286. JAPAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 287. JAPAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 288. JAPAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 289. JAPAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 290. JAPAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 291. JAPAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 292. JAPAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 293. MALAYSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 294. MALAYSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY NANOPARTICLE DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 295. MALAYSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIPID-BASED NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 296. MALAYSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMERIC NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 297. MALAYSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 298. MALAYSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 299. MALAYSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 300. MALAYSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY OCULAR, 2018-2030 (USD MILLION)
TABLE 301. MALAYSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 302. MALAYSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY SUBCUTANEOUS, 2018-2030 (USD MILLION)
TABLE 303. MALAYSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 304. MALAYSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 305. MALAYSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 306. MALAYSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 307. MALAYSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 308. MALAYSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 309. MALAYSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 310. MALAYSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 311. PHILIPPINES DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 312. PHILIPPINES DRUG DELIVERY SYSTEMS MARKET SIZE, BY NANOPARTICLE DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 313. PHILIPPINES DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIPID-BASED NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 314. PHILIPPINES DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMERIC NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 315. PHILIPPINES DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 316. PHILIPPINES DRUG DELIVERY SYSTEMS MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 317. PHILIPPINES DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 318. PHILIPPINES DRUG DELIVERY SYSTEMS MARKET SIZE, BY OCULAR, 2018-2030 (USD MILLION)
TABLE 319. PHILIPPINES DRUG DELIVERY SYSTEMS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 320. PHILIPPINES DRUG DELIVERY SYSTEMS MARKET SIZE, BY SUBCUTANEOUS, 2018-2030 (USD MILLION)
TABLE 321. PHILIPPINES DRUG DELIVERY SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 322. PHILIPPINES DRUG DELIVERY SYSTEMS MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 323. PHILIPPINES DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 324. PHILIPPINES DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 325. PHILIPPINES DRUG DELIVERY SYSTEMS MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 326. PHILIPPINES DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (

Companies Mentioned

  • Abbott Laboratories
  • AptarGroup, Inc.
  • AstraZeneca Plc
  • Boston Scientific Corporation
  • Cospheric LLC
  • DelSiTech Ltd.
  • Enable Injections, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Insulet Corporation
  • Johnson & Johnson Services, Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • Merit Medical Systems, Inc.
  • Novartis AG
  • Pacira BioSciences, Inc.
  • Pfizer Inc.
  • Polysciences Inc.
  • Sanofi S.A.
  • SHL Medical
  • Societal CDMO by CoreRx, Inc.
  • Terumo Corporation
  • Thermo Fisher Scientific Inc.
  • West Pharmaceutical Services, Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Ophthalmic Drug Delivery System Market by Drug Type, Delivery Device Type, Product Type, Formulation Type, Mode of Delivery, Application, End User - Global Forecast 2025-2030 - Product Image

Ophthalmic Drug Delivery System Market by Drug Type, Delivery Device Type, Product Type, Formulation Type, Mode of Delivery, Application, End User - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Novel Drug Delivery Systems Market by Route of Administration, Mode, End-User - Global Forecast 2025-2030 - Product Image

Novel Drug Delivery Systems Market by Route of Administration, Mode, End-User - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Gastroretentive Drug Delivery Systems Market Size, Share & Trends Analysis Report by Type (Floating, Expandable), Dosage (Tablets, Capsule, Gel, Liquid), Distribution Channel, Region, and Segment Forecasts, 2025-2030 - Product Image

Gastroretentive Drug Delivery Systems Market Size, Share & Trends Analysis Report by Type (Floating, Expandable), Dosage (Tablets, Capsule, Gel, Liquid), Distribution Channel, Region, and Segment Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From
Electronic Drug Delivery Systems Market Size, Share & Trends Analysis Report By Product, By Application, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Electronic Drug Delivery Systems Market Size, Share & Trends Analysis Report By Product, By Application, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Buccal Drug Delivery Systems Market (2024 Edition): Analysis By Product (Sublingual Films, Buccal Tablets and Lozenges, Oral Sprays), By Application, By Distribution Channel, By Region, By Country: Market Insights and Forecast (2020-2030) - Product Image

Buccal Drug Delivery Systems Market (2024 Edition): Analysis By Product (Sublingual Films, Buccal Tablets and Lozenges, Oral Sprays), By Application, By Distribution Channel, By Region, By Country: Market Insights and Forecast (2020-2030)

  • Report
  • 257 Pages
  • Global
From

About the Drug Delivery System Market

The Drug Delivery System market is a subset of the pharmaceutical industry that focuses on the development and manufacture of drug delivery systems. These systems are designed to deliver drugs to the body in a safe and effective manner. Drug delivery systems can be divided into two main categories: active and passive. Active drug delivery systems involve the use of a device to actively transport the drug to the target site, while passive drug delivery systems rely on the body's natural processes to deliver the drug. Drug delivery systems are used to improve the efficacy of drugs, reduce side effects, and increase patient compliance. They can also be used to target specific areas of the body, such as the lungs or the brain. The Drug Delivery System market is highly competitive, with many companies offering a variety of products and services. Some of the major players in the market include Pfizer, Novartis, Merck, Sanofi, and Johnson & Johnson. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.